2 results
Approved WMOCompleted
The objective of this trial is to demonstrate that bosentan delays disease worsening or death in patients with IPF.
Not approvedWill not start
To assess the efficacy of bosentan in neonates with persistent pulmonary hypertension of the newborn (PPHN) who are in need of continued inhaled nitric oxide (iNO) after at least 4 hours of continuous iNO treatment and to evaluate the…